- May 31, 2019
- Amy DuRoss
- Posted in Cell and Gene Therapy
Cell therapy and gene therapy versus cancer: 10 numbers to watch
Blog
ASCO 2019 is here! In 2018, ASCO named CAR-T cell therapy the cancer Advance of the Year, and this year’s ASCO brings more cell...
- May 30, 2019
- Vineti
- Posted in Supply Chain
When the patient is the product — some key challenges in cell and gene therapies
Blog
In personalized therapies — cell therapies, gene therapies, and neoantigen therapies — a patient is not just the recipient of...
- May 22, 2019
- Amy DuRoss
- Posted in Company Updates
Cell and gene therapy standards need you!
Blog
One week to go! In the next seven days, those of us working in cell and gene therapy have a...
- May 15, 2019
- Marc Puich
- Posted in Commercial Scale
Supply chain management readiness, Part 2: operational ecosystem
Blog
(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...
- May 9, 2019
- Vineti
- Posted in Company Updates
Cell and gene therapy news: some recent highlights
Blog
Things keep moving fast in the world of cell and gene therapy. Here are a few of the recent developments...
- May 2, 2019
- Heidi Hagen
- Posted in Commercial Scale
Commercial lessons for clinical-phase success, Part I: it all starts with collaboration
Blog
In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...